CME Presentations

Therapies for Early Alzheimer’s Disease



  • Monica Parsons, RN, BSN

    Monica Parsons, RN, BSN

    Monica Parsons, RN, BSN

    Director of Clinical Education

    Monica Parsons, RN, BSN is the director of clinical education for the National Infusion Center Association (NICA), where she is focused on developing resources and training material to support infusions and stakeholders. Prior to this, she spent over a decade in infusion therapy roles, starting as an infusion therapy nurse before serving as a clinical resource manager for Ol Infusion Services. She then served as director of quality and compliance at the Ambulatory Infusion Center. Monica has successfully led multiple ambulatory infusion clinics through accreditation, where she learned the value of an accreditation program designed by and for the ambulatory infusion industry.
  • Sarah Harlock, MBA

    Sarah Harlock, MBA

    Sarah Harlock, MBA

    Program Director

    Sarah Harlock, MBA has been working in the field of dementia care for more than 25 years. Her dedication began with her experience in skilled nursing facilities. She then transitioned to the Alzheimer's Association, Western New York Chapter, where she provided community education and implemented an innovative in-home care consultation program addressing dementia behavior management. After receiving her MBA, she became development director, coordinating the fundraising efforts of the local chapter. In her current role as program director of the Center for Cognitive Disorders and Brain Health at Dent Neurologic Institute in Amherst, NY, she oversees the day-to-day operations of a multi-faceted memory disorders program supporting medical providers, patients, and families.
  • Bela Ajtai, MD, PhD

    Bela Ajtai, MD, PhD

    Bela Ajtai, MD, PhD

    Attending Neurologist

    Bela Ajtai, MD, PhD is an attending neurologist at the Dent Neurologic Institute in Buffalo, NY, specializing in memory disorders, dementia, and neuroimaging diagnostics. He is board certified in these specialties by the American Board of Neurology and Psychiatry and by the United Council of Neurologic Subspecialties. Within neurology, his main field is cognitive disorders and dementia, with a special focus on Alzheimer's disease. He is the medical director of the Dent Center for Cognitive Disorders and Brain Health. He has also published several articles in peer-reviewed journals and authored and co-authored several book chapters. He serves as principal investigator in several multicenter dementia research studies.

CME Information

Global LogoPQH Logo

Practical Strategies to Enhance Patient Access to Infusion Biologic Therapies for Early Alzheimer’s Disease

Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the National Infusion Center Association (NICA).


This activity is supported by an independent medical education grant from Eisai, Inc.


This activity was released on November 17th, 2023 and is valid until November 17th, 2024. Requests for credit must be made no later than November 17th, 2024.


The educational design of this activity addresses the needs of – neurologists, geriatricians, specialty advanced practitioners, and primary care physicians.


Biologic infusion therapies, including anti-amyloid monoclonal antibodies, are now available for the treatment of people with mild cognitive impairment (MCI) and early Alzheimer’s disease. Early diagnosis, an understanding of new biomarkers, and strategies to address adverse events are crucial to fully leveraging the potential of these new therapies in the clinic and ensuring that each patient receives the right treatment. Join a neurologist and a representative from the National Infusion Center Association (NICA) to review the importance of and strategies for identifying and diagnosing patients with MCI and early Alzheimer’s disease. Panelists will discuss how to differentiate the mechanisms of action and the rationale for use of new and emerging anti-amyloid therapies, share strategies to enhance access to infusion centers and mitigate treatment-related adverse events, and explore ways to ensure patients and caregivers have the support they need to help break patient-related barriers.  


After completing this activity, the participant should be better able to:
  • Communicate treatment expectations to patients and families
  • Review solutions to orient patients and families to access complex biologic infusion therapies for Alzheimer’s disease
  • Identify educational resources and advocacy groups to support patients with Alzheimer’s disease at all disease stages
  • Develop strategies to monitor and mitigate imaging abnormalities and bleeding risk with anti-amyloid infusion therapy


JointlyAccreditedProvider Logo In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This activity should take approximately 60 minutes to complete.


In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a score of 75% on the post-test.


Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.


There is no fee for this educational activity.


PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:  
Name of Faculty or Presenter Conflicts of Interest
Bela Ajtai, MD, PhD Attending Neurologist DENT Neurologic Institute Speaker: Corium and Lilly
Sarah Harlock, MBA Program Director Integrative Center for Memory at DENT Neurologic Institute Nothing to Disclose
Monica Parsons, RN, BSN Director of Clinical Education National Infusion Center Association Nothing to Disclose
The PACE planners and others have no relevant financial relationship(s) to disclose with ineligible companies. The PlatformQ Health Education, LLC planners and others have no relevant financial relationship(s) to disclose with ineligible companies.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Accreditation Support:

For additional information about the accreditation of this activity, please visit

Technical Support:

For any technical issues or issues with your CME Certificate, please contact PsychiatryCareLive at 877-394-1306 or at